The insulin and insulin-like growth factor receptor family in neoplasia: an update (Q37984217)

26 August 2017

The insulin and insulin-like growth factor receptor family in neoplasia: an update (English)

1 reference

26 August 2017

1 reference

Michael Pollak

1

1 reference

PubMed ID

22337149

26 August 2017

language of work or name

English

0 references

publication date

16 February 2012

1 reference

26 August 2017

Nature Reviews Cancer

1 reference

26 August 2017

12

1 reference

26 August 2017

159-169

1 reference

26 August 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1038/nrc3215

26 August 2017

0 references

cites work

Insulin and insulin-like growth factor signalling in neoplasia

1 reference

Insulin-like growth factors and neoplasia.

31 March 2020

1 reference

Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type 1 insulin-like growth factor receptor

31 March 2020

1 reference

Hormone responsive human breast cancer in long-term tissue culture: effect of insulin

31 March 2020

1 reference

Minireview: IGF, Insulin, and Cancer

31 March 2020

1 reference

Insulin/IGF-I-signaling pathway: an evolutionarily conserved mechanism of longevity from yeast to humans

31 March 2020

1 reference

Insulin and its receptor: structure, function and evolution

31 March 2020

1 reference

Genetic analysis of insulin signaling in Drosophila

31 March 2020

1 reference

Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes

31 March 2020

1 reference

Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease.

31 March 2020

1 reference

Characterization of insulin/IGF hybrid receptors: contributions of the insulin receptor L2 and Fn1 domains and the alternatively spliced exon 11 sequence to ligand binding and receptor activation

31 March 2020

1 reference

Insulin-like growth factor I receptor signaling--overlapping or redundant pathways?

31 March 2020

1 reference

Increased insulin-like growth factor 1 receptor protein expression and gene copy number in small cell lung cancer.

31 March 2020

1 reference

Phosphorylated insulin-like growth factor-i/insulin receptor is present in all breast cancer subtypes and is related to poor survival.

31 March 2020

1 reference

Insulin receptor expression by human prostate cancers

31 March 2020

1 reference

Gene expression profiles in normal and cancer cells

31 March 2020

1 reference

Association of diet-induced hyperinsulinemia with accelerated growth of prostate cancer (LNCaP) xenografts

31 March 2020

1 reference

Diet and tumor LKB1 expression interact to determine sensitivity to anti-neoplastic effects of metformin in vivo.

31 March 2020

1 reference

Metformin abolishes increased tumor (18)F-2-fluoro-2-deoxy-D-glucose uptake associated with a high energy diet

31 March 2020

1 reference

Cellular mechanisms of insulin resistance: role of stress-regulated serine kinases and insulin receptor substrates (IRS) serine phosphorylation

31 March 2020

1 reference

Metformin blocks the stimulative effect of a high-energy diet on colon carcinoma growth in vivo and is associated with reduced expression of fatty acid synthase

31 March 2020

1 reference

Metformin attenuates the stimulatory effect of a high-energy diet on in vivo LLC1 carcinoma growth

31 March 2020

1 reference

A prospective study of plasma C-peptide and colorectal cancer risk in men

31 March 2020

1 reference

Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis

31 March 2020

1 reference

Genetic and environmental components of interindividual variation in circulating levels of IGF-I, IGF-II, IGFBP-1, and IGFBP-3.

31 March 2020

1 reference

Cellular actions of the insulin-like growth factor binding proteins

31 March 2020

1 reference

Targeting insulin-like growth factor signaling: rational combination strategies.

31 March 2020

1 reference

Emerging role of insulin-like growth factor receptor inhibitors in oncology: early clinical trial results and future directions

31 March 2020

1 reference

Cyclolignans as inhibitors of the insulin-like growth factor-1 receptor and malignant cell growth.

31 March 2020

1 reference

beta-cell-specific deletion of the Igf1 receptor leads to hyperinsulinemia and glucose intolerance but does not alter beta-cell mass

31 March 2020

1 reference

In vivo antitumor activity of NVP-AEW541-A novel, potent, and selective inhibitor of the IGF-IR kinase

31 March 2020

1 reference

IGF1/insulin receptor kinase inhibition by BMS-536924 is better tolerated than alloxan-induced hypoinsulinemia and more effective than metformin in the treatment of experimental insulin-responsive breast cancer

31 March 2020

1 reference

Dual IGF-I/II-neutralizing antibody MEDI-573 potently inhibits IGF signaling and tumor growth

31 March 2020

1 reference

Insulin receptor isoform A and insulin-like growth factor II as additional treatment targets in human osteosarcoma.

31 March 2020

1 reference

Safety, pharmacokinetics, and preliminary activity of the anti-IGF-1R antibody figitumumab (CP-751,871) in patients with sarcoma and Ewing's sarcoma: a phase 1 expansion cohort study

31 March 2020

1 reference

A phase I pharmacokinetic and pharmacodynamic study of dalotuzumab (MK-0646), an anti-insulin-like growth factor-1 receptor monoclonal antibody, in patients with advanced solid tumors.

31 March 2020

1 reference

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer

31 March 2020

1 reference

Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumab

31 March 2020

1 reference

ETV6-NTRK3-mediated breast epithelial cell transformation is blocked by targeting the IGF1R signaling pathway

31 March 2020

1 reference

Down-regulation of type I insulin-like growth factor receptor increases sensitivity of breast cancer cells to insulin.

31 March 2020

1 reference

Insulin receptor functionally enhances multistage tumor progression and conveys intrinsic resistance to IGF-1R targeted therapy

31 March 2020

1 reference

Synthetic lethality screens reveal RPS6 and MST1R as modifiers of insulin-like growth factor-1 receptor inhibitor activity in childhood sarcomas

31 March 2020

1 reference

A kinome-wide screen identifies the insulin/IGF-I receptor pathway as a mechanism of escape from hormone dependence in breast cancer

31 March 2020

1 reference

Insulin-like growth factor-I receptor signaling and resistance to trastuzumab (Herceptin).

31 March 2020

1 reference

Feedback mechanisms promote cooperativity for small molecule inhibitors of epidermal and insulin-like growth factor receptors

31 March 2020

1 reference

Insulin-like growth factor (IGF)-I rescues breast cancer cells from chemotherapy-induced cell death--proliferative and anti-apoptotic effects

31 March 2020

1 reference

Acquired resistance to BRAF inhibitors mediated by a RAF kinase switch in melanoma can be overcome by cotargeting MEK and IGF-1R/PI3K

31 March 2020

1 reference

Human melanoma cells expressing V600E B-RAF are susceptible to IGF1R targeting by small interfering RNAs

31 March 2020

1 reference

Insulin Increases De Novo Steroidogenesis in Prostate Cancer Cells

31 March 2020

1 reference

Co-targeting the insulin-like growth factor I receptor enhances growth-inhibitory and pro-apoptotic effects of anti-estrogens in human breast cancer cell lines

31 March 2020

1 reference

mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt

31 March 2020

1 reference

AKT inhibition relieves feedback suppression of receptor tyrosine kinase expression and activity

31 March 2020

1 reference

Hormonal impact of the 17alpha-hydroxylase/C(17,20)-lyase inhibitor abiraterone acetate (CB7630) in patients with prostate cancer

31 March 2020

1 reference

The phosphoinositide 3'-kinase delta inhibitor, CAL-101, inhibits B-cell receptor signaling and chemokine networks in chronic lymphocytic leukemia

31 March 2020

1 reference

Tacrolimus-Induced Diabetes in Rats Courses with Suppressed Insulin Gene Expression in Pancreatic Islets

31 March 2020

1 reference

Immortal time bias in pharmaco-epidemiology

31 March 2020

1 reference

Metformin and other biguanides in oncology: advancing the research agenda

31 March 2020

1 reference

AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function

31 March 2020

1 reference

Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state

31 March 2020

1 reference

Randomized trial of tamoxifen versus combined tamoxifen and octreotide LAR Therapy in the adjuvant treatment of early-stage breast cancer in postmenopausal women: NCIC CTG MA.14.

31 March 2020

1 reference

Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells

31 March 2020

1 reference

Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells

31 March 2020

1 reference

Relevance of the OCT1 transporter to the antineoplastic effect of biguanides

31 March 2020

1 reference

Mammalian MATE (SLC47A) transport proteins: impact on efflux of endogenous substrates and xenobiotics

31 March 2020

1 reference

Combination therapy with vemurafenib (PLX4032/RG7204) and metformin in melanoma cell lines with distinct driver mutations

31 March 2020

1 reference

Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth

31 March 2020

1 reference

Targeting cancer metabolism: a therapeutic window opens

31 March 2020

1 reference

Dual inhibition of tumor energy pathway by 2-deoxyglucose and metformin is effective against a broad spectrum of preclinical cancer models

31 March 2020

1 reference

Targeting cancer cell metabolism: the combination of metformin and 2-deoxyglucose induces p53-dependent apoptosis in prostate cancer cells

31 March 2020

1 reference

Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults

31 March 2020

1 reference

The global obesity pandemic: shaped by global drivers and local environments

31 March 2020

1 reference

Long-term low-protein, low-calorie diet and endurance exercise modulate metabolic factors associated with cancer risk

31 March 2020

1 reference

Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression

31 March 2020

1 reference

Tumours with PI3K activation are resistant to dietary restriction

31 March 2020

1 reference

Diabetes and Cancer: A Consensus Report

31 March 2020

1 reference

Can endogenous hyperinsulinaemia explain the increased risk of cancer development and mortality in type 2 diabetes: evidence from mouse models

31 March 2020

1 reference

Glucose-lowering agents and cancer mortality rates in type 2 diabetes: assessing effects of time-varying exposure.

31 March 2020

1 reference

Direct comparison of insulin lispro and aspart shows small differences in plasma insulin profiles after subcutaneous injection in type 1 diabetes

31 March 2020

1 reference

Cyclic Oscillations of Basal Plasma Glucose and Insulin Concentrations in Human Beings

31 March 2020

1 reference

Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use

31 March 2020

1 reference

Differences in bioactivity between human insulin and insulin analogues approved for therapeutic use- compilation of reports from the past 20 years

31 March 2020

1 reference

Insulin X10 revisited: a super-mitogenic insulin analogue

31 March 2020

1 reference

Insulin glargine and malignancy: an unwarranted alarm

31 March 2020

1 reference

Insulin glargine and cancer: another side to the story?

31 March 2020

1 reference

Inhaled insulin's last gasp?

31 March 2020

1 reference

Influence of unrecognized molecular heterogeneity on randomized clinical trials

31 March 2020

1 reference

Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain

31 March 2020

1 reference

12 December 2020

Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study.

1 reference

12 December 2020

Phase II study of figitumumab in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: clinical activity and molecular response (GORTEC 2008-02).

1 reference

12 December 2020

Reduced growth of human breast cancer xenografts in hosts homozygous for the lit mutation

1 reference

12 December 2020

Figitumumab combined with carboplatin and paclitaxel in treatment-naïve Japanese patients with advanced non-small cell lung cancer

1 reference

12 December 2020

Insulin-like growth factor-I receptor overexpression mediates cellular radioresistance and local breast cancer recurrence after lumpectomy and radiation

1 reference

12 December 2020

Metformin reduces endogenous reactive oxygen species and associated DNA damage

1 reference

12 December 2020

Insulin-like growth factor receptor I mediates resistance to anti-epidermal growth factor receptor therapy in primary human glioblastoma cells through continued activation of phosphoinositide 3-kinase signaling

1 reference

12 December 2020

Gefitinib resistance in HCC mahlavu cells: upregulation of CD133 expression, activation of IGF-1R signaling pathway, and enhancement of IGF-1R nuclear translocation

1 reference

12 December 2020

Prognostic impact of insulin receptor expression on survival of patients with nonsmall cell lung cancer

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRC3215

1 reference

26 August 2017

1 reference

PubMed ID

22337149